Video: Superheroes, Secret Identities & You| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: Primary care

Interstitial Lung Disease: What Rheumatologists Need to Know

Gretchen Henkel  |  May 18, 2019

In the past decade, the treat-to-target concept has gained broad acceptance. Both the ACR and European League Against Rheumatism (EULAR) management recommendations include adding biologic therapies to the treatment regimen for rheumatoid arthritis (RA) patients who do not sufficiently respond to methotrexate monotherapy. “What EULAR says is that if [metho­trexate use fails], you should essentially…

Filed under:Conditions Tagged with:Interstitial Lung Disease

Arizona Project Trains Rural Clinics to Triage & Refer Rheumatic Disease Cases

Linda Childers  |  May 18, 2019

Dominick Sudano, MD, an assistant professor at the University of Arizona and rheumatologist at Banner University Medical Center, Tucson, Ariz., knows how tough it is for patients living in remote areas to obtain a rheumatology consultation. “It’s not unusual for patients living in rural areas of Arizona to wait four to six months for a…

Filed under:Education & TrainingProfessional Topics Tagged with:Access to care

The Latest Awards, Appointments & Announcements in Rheumatology

Gretchen Henkel  |  May 17, 2019

Paul Sufka Named Social Media Editor for New ACR Twitter Account A clinical rheumatologist with HealthPartners in St. Paul, Minn., Paul Sufka, MD, is conversant with social media: he’s been on Twitter for almost 10 years; has hosted an online rheumatology podcast; and blogs about physician self-care and using Twitter as a tool at medical…

Filed under:AwardsProfiles Tagged with:Dr. Carlos PinedaDr. Linda BradyDr. Paul SufkaDr. Saira Sheikh

A Case of Eosinophilic Fasciitis Presenting with Pansclerotic Morphea

Julia K. Munchel, MD, & William E. Monaco, MD  |  May 17, 2019

Eosinophilic fasciitis generally presents with the acute onset of edema followed by progressive skin induration in the setting of hypergammaglobulinemia, an elevated erythrocyte sedimentation rate (ESR) and peripheral eosinophilia in 63–93% of patients.1,2 Skin involvement is typically limited to 20.1% of total body surface area and most commonly involves the extremities symmetrically.1,3 The condition was…

Filed under:ConditionsSystemic Sclerosis Tagged with:eosinophilic fasciitispansclerotic morphea

Annual AMA Committee Meetings Present Large-Scale Survey Results on E/M Codes

From the College  |  May 15, 2019

The American Medical Association’s (AMA) Relative Value Scale (RVS) Update Committee (RUC) and Current Procedural Terminology (CPT) Committee currently meet three times a year each to keep the CPT code set up to date, and to review the valuation of all the codes for the physician fee schedule. The two-step meetings of both the CPT Editorial…

Filed under:American College of RheumatologyFrom the College Tagged with:AMA Relative Value Update Committee (RUC)American Medical Association (AMA)Current Procedural Terminology Committee (CPT)evaluation and management (E/M)RUC/CPT meeting

U.S. Government Website for Comparing Doctors Lacks Data

Lisa Rapaport  |  May 8, 2019

(Reuters Health)—Physician Compare, a U.S. website created to help patients find high-quality doctors, is missing so much information on individual providers that it may not be helpful, a new study suggests. Quality reporting has been a work in progress for almost three decades since a landmark 1999 report from the Institute of Medicine, ‘To Err…

Filed under:Professional Topics Tagged with:Centers for Medicare & Medicaid Services (CMS)decision-makingpatientphysicianPhysician Compare

Patients Value Convenience of Telemedicine

Lisa Rapaport  |  April 30, 2019

(Reuters Health)—Patients who have real-time video visits with their primary care providers instead of in-person exams are generally satisfied with the convenience and quality of their checkups, a new study suggests. There’s a lot about these telemedicine visits that can sound appealing: no need to get stuck in traffic on the way to the doctor;…

Filed under:Technology Tagged with:patient carepatient perspectivetelemedicinevideo-based telemedicine

More Data for Treat to Target: Post-Hoc Analysis of Large RA Clinical Trials Supports Treat-to-Target Recommendations

Gretchen Henkel  |  April 17, 2019

A post-hoc analysis of data from two large clinical trials supports treat-to-target recommendations for patients with rheumatoid arthritis. The research found baseline disease activity was the strongest predictor of a patient’s insufficient response to initial therapy at six months…

Filed under:ConditionsRheumatoid Arthritis Tagged with:biologic therapiesrecommendationsRheumatoid Arthritis (RA)Treat-to-Target

Experts Offer Management Tips, from Contracts to Credentials to Audits

Thomas R. Collins  |  April 15, 2019

CHICAGO—Medical practice consultant Owen Dahl, MBA, LFACHE, CHBC, looked out at the rheumatology practice managers and physicians, sitting around tables with white tablecloths, and asked what seemed like a simple question: “How many of you have a strategic plan?” he asked. A single hand was raised. “One? How do you know where to go tomorrow…

Filed under:Practice Support Tagged with:2018 ACR/ARHP Annual MeetingAuditsComplianceContractcredentialing

Tips for Interdisciplinary Pain Management in Older Patients

Susan Bernstein  |  April 15, 2019

CHICAGO—Rheumatology healthcare providers should embrace collaborative approaches to manage chronic musculoskeletal pain in older adult patients, including models of care that involve multiple providers, patients and their caregivers. That was the message delivered by two speakers in the Interdisciplinary Management of Chronic Musculo­skeletal Pain in Older Adults session at the 2018 ACR/ARHP Annual Meeting. “As…

Filed under:AnalgesicsConditions Tagged with:2018 ACR/ARHP Annual MeetingbiopsychosocialcollaborationExerciseinterdisciplinaryPain Managementstepped care

  • « Previous Page
  • 1
  • …
  • 28
  • 29
  • 30
  • 31
  • 32
  • …
  • 137
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences